INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "DOSING REGIMEN FOR THERAPIES COMPRISING BISPECIFIC ANTIEGFR/C-MET ANTIBODIES"

GENEVA, Jan. 27 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/IB2024/056510) for "DOSING REGIMEN FOR THERAPIES COMPRISING BISPECIFIC ANTIEGFR/C-MET ANTIBODIES" on Jul 03, 2024. With publication no. WO/2025/017409, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KNOBLAUCH, Roland (1400 McKean RoadSpring House, Pennsylvania 19477)

Abstract: Provided are methods of treating an epidermal growth factor receptor (EGFR)-expressing or hepatocyte growth factor rece...